Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$145.48 - $167.38 $6.05 Million - $6.96 Million
41,600 Added 26.55%
198,300 $32.1 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $34.4 Million - $37.6 Million
-238,300 Reduced 60.33%
156,700 $22.9 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $3.6 Million - $3.78 Million
23,200 Added 6.24%
395,000 $62.5 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $2.14 Million - $2.34 Million
-14,700 Reduced 3.8%
371,800 $58.3 Million
Q3 2023

Nov 15, 2023

BUY
$155.75 - $174.48 $60.2 Million - $67.4 Million
386,500 New
386,500 $60.2 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.